Fluvoxamine maleate is a potent selective serotonin (5-HT) reuptake inhibitor (SSRI). Inhibits CNS neuron serotonin uptake; minimal or no effect on reuptake of norepinephrine or dopamine; does not significantly bind to alpha-adrenergic, histamine or cholinergic receptors.